317 related articles for article (PubMed ID: 18374507)
1. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
4. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
5. Perioperative brachytherapy as an additional therapeutic option in patients with renal cell carcinoma (RCC), either inoperable or after completed percutaneous radiotherapy.
Kwiatkowski J; Schmidt B; Merkle P; Keller K
Anticancer Res; 1999; 19(2C):1597-9. PubMed ID: 10365153
[TBL] [Abstract][Full Text] [Related]
6. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
7. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Lax I; Kälkner KM; Linder C; Lundell G; Nilsson B; Nilsson S; Näslund I; Pisa P; Svedman C
Radiother Oncol; 2005 Oct; 77(1):88-95. PubMed ID: 15972239
[TBL] [Abstract][Full Text] [Related]
8. Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience.
Carini M; Minervini A; Masieri L; Lapini A; Serni S
Eur Urol; 2006 Dec; 50(6):1263-8; discussion 1269-71. PubMed ID: 16787695
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
Margulis V; Sánchez-Ortiz RF; Tamboli P; Cohen DD; Swanson DA; Wood CG
Cancer; 2007 May; 109(10):2025-30. PubMed ID: 17420980
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
[TBL] [Abstract][Full Text] [Related]
12. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
[TBL] [Abstract][Full Text] [Related]
13. The value of postoperative radiotherapy in advanced renal cell cancer.
Makarewicz R; Zarzycka M; Kulińska G; Windorbska W
Neoplasma; 1998; 45(6):380-3. PubMed ID: 10210113
[TBL] [Abstract][Full Text] [Related]
14. [Intraoperative electron irradiation (IORT) of urologic tumors. Initial results of a pilot study of local recurrences of renal cell cancers].
Beer M; Eble MJ; Wannenmacher M; Staehler G
Urologe A; 1994 Mar; 33(2):110-5. PubMed ID: 8178404
[TBL] [Abstract][Full Text] [Related]
15. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
[TBL] [Abstract][Full Text] [Related]
16. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma.
Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y
Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729
[TBL] [Abstract][Full Text] [Related]
18. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
19. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
